It is found that FOXP1 is abnormally expressed in various tumors such as breast cancer, lung cancer, bladder cancer, and lymphoma, which may become a tumor marker for clinical practice [11,12]. The gene discussed is FOXP1; the disease is urinary bladder cancer.